| Financial Year |
March 31 2023 |
| Monetary Funds |
690,050,501.23 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
142,043,210.53 |
| Advances to Suppliers |
38,275,244.21 |
| Other Receivables |
26,112,896.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
241,328,362.88 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
232,300.53 |
| Other Current Assets |
8,572,481.17 |
| Total Current Assets |
1,146,614,996.96 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
122,264,389.27 |
| Long-term Equity Investment |
2,099,764,084.84 |
| Investment Properties |
46,501,375.64 |
| Fixed Assetes |
367,184,965.13 |
| Under-construction Projects |
8,705,467.50 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
197,642,482.39 |
| R&D expenses |
-- |
| Goodwill |
373,820,764.30 |
| Long-Term Deferred and Prepaid Expenses |
165,985,145.53 |
| Deferred Income Tax Assets |
10,872,719.75 |
| Other Non-Current Assets |
1,982,100.05 |
| Sub-Total of Non-Current Assets |
4,438,187,380.81 |
| Total Assets |
5,584,802,377.78 |
| Short-Term Loans |
699,594,079.36 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
380,138,380.77 |
| Accounts Received In Advance |
4,882,257.74 |
| Employee Compensation Payable |
42,107,112.45 |
| Taxes Payable |
35,502,689.74 |
| Interest Payable |
30,680.50 |
| Dividend Payable |
-- |
| Other payables |
212,980,790.80 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
37,526,101.99 |
| Other Current Liabilities |
25,568,367.13 |
| Sub-Total of Current Liabilities |
1,626,380,387.78 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
42,880,078.27 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
184,674,339.76 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
520,609,908.80 |
| Total Liabilities |
2,146,990,296.58 |
| Paid-In Capital(Or Share Stock) |
884,779,518.00 |
| Capital Surplus |
71,175,772.93 |
| Surplus Reserve |
379,916,301.84 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,430,970,296.16 |
| Minority Stockholder's Interest |
200,718,704.17 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,237,093,377.02 |
| Owner's Equity（Stockholder's Equity） |
3,437,812,081.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,584,802,377.78 |
